neb buffers composition (New England Biolabs)
94
Structured Review
New England Biolabs
neb buffers composition
Neb Buffers Composition, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neb+buffers+composition/NEBuffer+Set/pmc12120656__ao4c11282_si_001-49-214-214
Average 94 stars, based on 12 article reviews
Neb Buffers Composition, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neb+buffers+composition/NEBuffer+Set/pmc12120656__ao4c11282_si_001-49-214-214
Average 94 stars, based on 12 article reviews
neb buffers composition - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Sequencing:Article Title: Fusions of Catalytically Inactive RusA to FokI Nuclease Coupled with PNA Enable Programmable Site-Specific Double-Stranded DNA Breaks Article Snippet: Strand Strand Sequence 5’ to 3’ S1 AGCTGATCGTACGATGCTAGTCGTCCATCAGGCTAGTCGATGCTAGCTGA CGTAGCTGATCGTAGCATCGTGCAGCTGATCGTAGCATCCGAATCA S2 ACGATGCTCGATCGATGCATGCTAGTCGACGTCGATCGTACGATGCTAGT CGATGCTAGCTGAGCTGCTAGGACGACTAGCATCGTACGATCAGCT S3 GCTAGCTAGTCGATCGTAGCATATCCTAGCAGCTCAGCTAGCATCGACTA GCATCGTACGATCGACGTCGACTAGCATGCATCGATCGAGCATCGT S4 TGATTCGGATGCTACGATCAGCTGCACGATGCTACGATCAGCTACGTCAG CTAGCATCGACTAGCCTGATGGATATGCTACGATCGACTAGCTAGC Table S5: Top and bottom oligos used to clone the target sequences in pUC19 vectors Oligo name Oligo sequence (5’---3’) 151-γPNA1-top with NdeI TACACAGGGTGGTCACGAGGGTGGGCTGACTGTACAACA TCCGCATTGAGAACCTCCCTTGAG 151-γPNA1-bottom with NdeI TACTCAAGGGAGGTTCTCAATGCGGATGTTGTACAGTCA GCCCACCCTCGTGACCACCCTGTG Table S6: Primers used in the current study Primer name Prime Sequence (5’ --- 3’) Employed for pET28 seq F GCATGACTGGTGGACAGCAA Sanger sequencing of pET28A-RusA expression clones pET28 seq R AGAGGCCCCAAGGGGTTATG 151-pUC19-PNA1-F TGTCTGTAAGCGGATGCCGG All the pUC19 target plasmids confirmation by Sanger sequencing, PCR amplification of pUC19 targets for producing the 151-pUC19-PNA1-R GCCAGCTGGCGTAATAGCG Table S7: Compositions of buffers used in this study Buffer Composition 1X Expressing:Article Title: Fusions of Catalytically Inactive RusA to FokI Nuclease Coupled with PNA Enable Programmable Site-Specific Double-Stranded DNA Breaks Article Snippet: Strand Strand Sequence 5’ to 3’ S1 AGCTGATCGTACGATGCTAGTCGTCCATCAGGCTAGTCGATGCTAGCTGA CGTAGCTGATCGTAGCATCGTGCAGCTGATCGTAGCATCCGAATCA S2 ACGATGCTCGATCGATGCATGCTAGTCGACGTCGATCGTACGATGCTAGT CGATGCTAGCTGAGCTGCTAGGACGACTAGCATCGTACGATCAGCT S3 GCTAGCTAGTCGATCGTAGCATATCCTAGCAGCTCAGCTAGCATCGACTA GCATCGTACGATCGACGTCGACTAGCATGCATCGATCGAGCATCGT S4 TGATTCGGATGCTACGATCAGCTGCACGATGCTACGATCAGCTACGTCAG CTAGCATCGACTAGCCTGATGGATATGCTACGATCGACTAGCTAGC Table S5: Top and bottom oligos used to clone the target sequences in pUC19 vectors Oligo name Oligo sequence (5’---3’) 151-γPNA1-top with NdeI TACACAGGGTGGTCACGAGGGTGGGCTGACTGTACAACA TCCGCATTGAGAACCTCCCTTGAG 151-γPNA1-bottom with NdeI TACTCAAGGGAGGTTCTCAATGCGGATGTTGTACAGTCA GCCCACCCTCGTGACCACCCTGTG Table S6: Primers used in the current study Primer name Prime Sequence (5’ --- 3’) Employed for pET28 seq F GCATGACTGGTGGACAGCAA Sanger sequencing of pET28A-RusA expression clones pET28 seq R AGAGGCCCCAAGGGGTTATG 151-pUC19-PNA1-F TGTCTGTAAGCGGATGCCGG All the pUC19 target plasmids confirmation by Sanger sequencing, PCR amplification of pUC19 targets for producing the 151-pUC19-PNA1-R GCCAGCTGGCGTAATAGCG Table S7: Compositions of buffers used in this study Buffer Composition 1X Clone Assay:Article Title: Fusions of Catalytically Inactive RusA to FokI Nuclease Coupled with PNA Enable Programmable Site-Specific Double-Stranded DNA Breaks Article Snippet: Strand Strand Sequence 5’ to 3’ S1 AGCTGATCGTACGATGCTAGTCGTCCATCAGGCTAGTCGATGCTAGCTGA CGTAGCTGATCGTAGCATCGTGCAGCTGATCGTAGCATCCGAATCA S2 ACGATGCTCGATCGATGCATGCTAGTCGACGTCGATCGTACGATGCTAGT CGATGCTAGCTGAGCTGCTAGGACGACTAGCATCGTACGATCAGCT S3 GCTAGCTAGTCGATCGTAGCATATCCTAGCAGCTCAGCTAGCATCGACTA GCATCGTACGATCGACGTCGACTAGCATGCATCGATCGAGCATCGT S4 TGATTCGGATGCTACGATCAGCTGCACGATGCTACGATCAGCTACGTCAG CTAGCATCGACTAGCCTGATGGATATGCTACGATCGACTAGCTAGC Table S5: Top and bottom oligos used to clone the target sequences in pUC19 vectors Oligo name Oligo sequence (5’---3’) 151-γPNA1-top with NdeI TACACAGGGTGGTCACGAGGGTGGGCTGACTGTACAACA TCCGCATTGAGAACCTCCCTTGAG 151-γPNA1-bottom with NdeI TACTCAAGGGAGGTTCTCAATGCGGATGTTGTACAGTCA GCCCACCCTCGTGACCACCCTGTG Table S6: Primers used in the current study Primer name Prime Sequence (5’ --- 3’) Employed for pET28 seq F GCATGACTGGTGGACAGCAA Sanger sequencing of pET28A-RusA expression clones pET28 seq R AGAGGCCCCAAGGGGTTATG 151-pUC19-PNA1-F TGTCTGTAAGCGGATGCCGG All the pUC19 target plasmids confirmation by Sanger sequencing, PCR amplification of pUC19 targets for producing the 151-pUC19-PNA1-R GCCAGCTGGCGTAATAGCG Table S7: Compositions of buffers used in this study Buffer Composition 1X Polymerase Chain Reaction:Article Title: Fusions of Catalytically Inactive RusA to FokI Nuclease Coupled with PNA Enable Programmable Site-Specific Double-Stranded DNA Breaks Article Snippet: Strand Strand Sequence 5’ to 3’ S1 AGCTGATCGTACGATGCTAGTCGTCCATCAGGCTAGTCGATGCTAGCTGA CGTAGCTGATCGTAGCATCGTGCAGCTGATCGTAGCATCCGAATCA S2 ACGATGCTCGATCGATGCATGCTAGTCGACGTCGATCGTACGATGCTAGT CGATGCTAGCTGAGCTGCTAGGACGACTAGCATCGTACGATCAGCT S3 GCTAGCTAGTCGATCGTAGCATATCCTAGCAGCTCAGCTAGCATCGACTA GCATCGTACGATCGACGTCGACTAGCATGCATCGATCGAGCATCGT S4 TGATTCGGATGCTACGATCAGCTGCACGATGCTACGATCAGCTACGTCAG CTAGCATCGACTAGCCTGATGGATATGCTACGATCGACTAGCTAGC Table S5: Top and bottom oligos used to clone the target sequences in pUC19 vectors Oligo name Oligo sequence (5’---3’) 151-γPNA1-top with NdeI TACACAGGGTGGTCACGAGGGTGGGCTGACTGTACAACA TCCGCATTGAGAACCTCCCTTGAG 151-γPNA1-bottom with NdeI TACTCAAGGGAGGTTCTCAATGCGGATGTTGTACAGTCA GCCCACCCTCGTGACCACCCTGTG Table S6: Primers used in the current study Primer name Prime Sequence (5’ --- 3’) Employed for pET28 seq F GCATGACTGGTGGACAGCAA Sanger sequencing of pET28A-RusA expression clones pET28 seq R AGAGGCCCCAAGGGGTTATG 151-pUC19-PNA1-F TGTCTGTAAGCGGATGCCGG All the pUC19 target plasmids confirmation by Sanger sequencing, PCR amplification of pUC19 targets for producing the 151-pUC19-PNA1-R GCCAGCTGGCGTAATAGCG Table S7: Compositions of buffers used in this study Buffer Composition 1X Amplification:Article Title: Fusions of Catalytically Inactive RusA to FokI Nuclease Coupled with PNA Enable Programmable Site-Specific Double-Stranded DNA Breaks Article Snippet: Strand Strand Sequence 5’ to 3’ S1 AGCTGATCGTACGATGCTAGTCGTCCATCAGGCTAGTCGATGCTAGCTGA CGTAGCTGATCGTAGCATCGTGCAGCTGATCGTAGCATCCGAATCA S2 ACGATGCTCGATCGATGCATGCTAGTCGACGTCGATCGTACGATGCTAGT CGATGCTAGCTGAGCTGCTAGGACGACTAGCATCGTACGATCAGCT S3 GCTAGCTAGTCGATCGTAGCATATCCTAGCAGCTCAGCTAGCATCGACTA GCATCGTACGATCGACGTCGACTAGCATGCATCGATCGAGCATCGT S4 TGATTCGGATGCTACGATCAGCTGCACGATGCTACGATCAGCTACGTCAG CTAGCATCGACTAGCCTGATGGATATGCTACGATCGACTAGCTAGC Table S5: Top and bottom oligos used to clone the target sequences in pUC19 vectors Oligo name Oligo sequence (5’---3’) 151-γPNA1-top with NdeI TACACAGGGTGGTCACGAGGGTGGGCTGACTGTACAACA TCCGCATTGAGAACCTCCCTTGAG 151-γPNA1-bottom with NdeI TACTCAAGGGAGGTTCTCAATGCGGATGTTGTACAGTCA GCCCACCCTCGTGACCACCCTGTG Table S6: Primers used in the current study Primer name Prime Sequence (5’ --- 3’) Employed for pET28 seq F GCATGACTGGTGGACAGCAA Sanger sequencing of pET28A-RusA expression clones pET28 seq R AGAGGCCCCAAGGGGTTATG 151-pUC19-PNA1-F TGTCTGTAAGCGGATGCCGG All the pUC19 target plasmids confirmation by Sanger sequencing, PCR amplification of pUC19 targets for producing the 151-pUC19-PNA1-R GCCAGCTGGCGTAATAGCG Table S7: Compositions of buffers used in this study Buffer Composition 1X Recombinant:Article Title: Fusions of Catalytically Inactive RusA to FokI Nuclease Coupled with PNA Enable Programmable Site-Specific Double-Stranded DNA Breaks Article Snippet: Strand Strand Sequence 5’ to 3’ S1 AGCTGATCGTACGATGCTAGTCGTCCATCAGGCTAGTCGATGCTAGCTGA CGTAGCTGATCGTAGCATCGTGCAGCTGATCGTAGCATCCGAATCA S2 ACGATGCTCGATCGATGCATGCTAGTCGACGTCGATCGTACGATGCTAGT CGATGCTAGCTGAGCTGCTAGGACGACTAGCATCGTACGATCAGCT S3 GCTAGCTAGTCGATCGTAGCATATCCTAGCAGCTCAGCTAGCATCGACTA GCATCGTACGATCGACGTCGACTAGCATGCATCGATCGAGCATCGT S4 TGATTCGGATGCTACGATCAGCTGCACGATGCTACGATCAGCTACGTCAG CTAGCATCGACTAGCCTGATGGATATGCTACGATCGACTAGCTAGC Table S5: Top and bottom oligos used to clone the target sequences in pUC19 vectors Oligo name Oligo sequence (5’---3’) 151-γPNA1-top with NdeI TACACAGGGTGGTCACGAGGGTGGGCTGACTGTACAACA TCCGCATTGAGAACCTCCCTTGAG 151-γPNA1-bottom with NdeI TACTCAAGGGAGGTTCTCAATGCGGATGTTGTACAGTCA GCCCACCCTCGTGACCACCCTGTG Table S6: Primers used in the current study Primer name Prime Sequence (5’ --- 3’) Employed for pET28 seq F GCATGACTGGTGGACAGCAA Sanger sequencing of pET28A-RusA expression clones pET28 seq R AGAGGCCCCAAGGGGTTATG 151-pUC19-PNA1-F TGTCTGTAAGCGGATGCCGG All the pUC19 target plasmids confirmation by Sanger sequencing, PCR amplification of pUC19 targets for producing the 151-pUC19-PNA1-R GCCAGCTGGCGTAATAGCG Table S7: Compositions of buffers used in this study Buffer Composition 1X |